Literature DB >> 8676476

High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.

X Li1, P Coffino.   

Abstract

Human papillomavirus (HPV) E6 protein can inactivate tumor suppressor p53 by inducing its degradation. We now find that high-risk HPV E6 binds to p53 at two distinct sites; one is within the core structure of p53, and another is at the C terminus of p53. Binding to the core of p53 is required for E6-mediated degradation, as shown by deletion analysis and the properties of a point mutant at residue 135. Both low- and high-risk HPV E6 can bind to a C-terminal region of p53, but these interactions do not induce degradation. These results resolve previous seemingly contradictory findings that attributed the distinctive functional properties of high- and low-risk E6 proteins to either a difference in their abilities to associate with p53 or a difference in their N-terminal structures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676476      PMCID: PMC190386     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620+ p53 conformation.

Authors:  E A Medcalf; J Milner
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

2.  Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.

Authors:  K Iwabuchi; B Li; P Bartel; S Fields
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

3.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

4.  Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.

Authors:  D R Chowdary; J J Dermody; K K Jha; H L Ozer
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

5.  A 26 S protease subunit that binds ubiquitin conjugates.

Authors:  Q Deveraux; V Ustrell; C Pickart; M Rechsteiner
Journal:  J Biol Chem       Date:  1994-03-11       Impact factor: 5.157

6.  Inhibition of p53 DNA binding by human papillomavirus E6 proteins.

Authors:  M S Lechner; L A Laimins
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

8.  Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein.

Authors:  X Li; P Coffino
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Analysis of a protein-binding domain of p53.

Authors:  J M Ruppert; B Stillman
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  57 in total

1.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.

Authors:  S Nakagawa; J M Huibregtse
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.

Authors:  Deborah Stewart; Anirban Ghosh; Greg Matlashewski
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

6.  Viral oncoproteins discriminate between p53 and the p53 homolog p73.

Authors:  M C Marin; C A Jost; M S Irwin; J A DeCaprio; D Caput; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

7.  p53 protein is a suppressor of papillomavirus DNA amplificational replication.

Authors:  D Lepik; I Ilves; A Kristjuhan; T Maimets; M Ustav
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.

Authors:  Shiyuan Hong; Kavi P Mehta; Laimonis A Laimins
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

9.  Cell-specific modulation of papovavirus replication by tumor suppressor protein p53.

Authors:  D Lepik; M Ustav
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

10.  Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.

Authors:  Van K Morris; Asif Rashid; Miguel Rodriguez-Bigas; Prajnan Das; George Chang; Aki Ohinata; Jane Rogers; Christopher Crane; Robert A Wolff; Cathy Eng
Journal:  Oncologist       Date:  2015-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.